New studies into retatrutide, a dual activator for GLP-1 and GIP receptors, are demonstrating significant results in treating weight gain and related second-type disease. Initial evidence suggest a distinct mechanism https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/